Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Crypto

MicroStrategy Halts 12-Week Bitcoin Buying Spree, Signals Shift to Fixed-Income Strategy

by Team Lumida
February 3, 2025
in Crypto
Reading Time: 3 mins read
A A
0
a close up of a pile of coins

Photo by Traxer on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com
• MicroStrategy’s Bitcoin holdings reach $44.7 billion, representing 2% of total possible supply
• Company aims to raise $42 billion through 2027 via various financial instruments
• Stock has surged over 2,200% since end of 2022
• Company shifting focus to fixed-income securities in Q1 2025

What Happened?

MicroStrategy has ended its 12-week streak of Bitcoin purchases that began in late October 2024. During this period, the company acquired over $20 billion in Bitcoin, bringing its total holdings to $44.7 billion. The buying spree coincided with a significant Bitcoin rally driven partly by Donald Trump’s pro-digital asset stance. The company recently raised $563 million through perpetual strike preferred stock and has been utilizing various funding mechanisms, including at-the-market stock sales and convertible debt offerings.

Why It Matters?

This pause in Bitcoin acquisition signals a potential strategic shift for MicroStrategy, which has become a de facto Bitcoin investment vehicle under Michael Saylor’s leadership. The company’s aggressive accumulation strategy has transformed it into a significant player in the crypto market, holding over 2% of Bitcoin’s maximum supply. The company’s stock performance reflects this transformation, with shares rising more than 2,200% since late 2022. The strategy has also attracted hedge funds pursuing convertible arbitrage strategies, adding another dimension to the company’s market impact.

What’s Next?

Investors should focus on MicroStrategy’s upcoming earnings call on Wednesday, where management is expected to detail future capital raising plans and potential strategy adjustments. Key areas to watch include the company’s shift toward fixed-income securities in Q1 2025, as indicated by Saylor in December, and any revisions to the $42 billion capital raising target through 2027. The impact of Trump’s new tariffs on cryptocurrency markets (Bitcoin down 2% on Monday) may also influence the company’s strategy. Analyst Mark Palmer of Benchmark, maintaining a “buy” rating, suggests the company’s aggressive capital raising and Bitcoin purchasing strategy may be reassessed during the earnings call.

Source
Previous Post

Bond Market Signals Stagflation Risk as Trump Tariffs Trigger Yield Curve Flattening

Next Post

Nvidia Shares Tumble Amid Double Threat of Trump Tariffs and AI Competition

Recommended For You

BlackRock’s Bitcoin ETF Sees Record $6.35 Billion Inflows Amid May Rally

by Team Lumida
2 days ago
Is BlackRock the New Leader in Alternative Investments?

Key Takeaways: Powered by lumidawealth.com BlackRock’s iShares Bitcoin Trust (IBIT) recorded its largest-ever monthly inflow in May, attracting $6.35 billion and lifting total assets under management to over $71...

Read more

Bitcoin ETFs Attract $9 Billion as Investors Shift Away from Gold

by Team Lumida
3 days ago
Bitcoin Mining Stocks Outperform BTC in Early 2025, Network Strength Grows

Key Takeaways: Powered by lumidawealth.com Over the past five weeks, U.S. Bitcoin ETFs have seen inflows exceeding $9 billion, led by BlackRock’s iShares Bitcoin Trust ETF (IBIT), while gold-backed...

Read more

Ether Poised for Breakout Above $3,000 as Bullish Pattern Emerges

by Team Lumida
4 days ago
black and white star logo

Key Takeaways: Powered by lumidawealth.com Ether (ETH) is forming an ascending triangle pattern, a bullish technical indicator, suggesting a potential breakout above $3,000. The 50-day Simple Moving Average (SMA)...

Read more

Bitcoin Faces Risk of Pullback to $100K Amid Bearish Momentum Divergence

by Team Lumida
5 days ago
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Key Takeaways: Powered by lumidawealth.com Bitcoin’s bull run has stalled near $108,000, with technical indicators signaling a potential pullback to the $100,000 support level. The 30-day rate of change...

Read more

Ethereum Rebounds from $2,477 Support Amid Heavy Trading Volume, Eyes $2,530 Breakout

by Team Lumida
6 days ago
gold and black star print round ornament

Key Takeaways: Powered by lumidawealth.com Ethereum (ETH) rebounded strongly from the $2,477 support level, driven by extraordinary trading volume nearly three times the average. The cryptocurrency is navigating a...

Read more

Big Banks Explore Joint Stablecoin to Compete with Crypto Industry

by Team Lumida
1 week ago
Big Banks Explore Joint Stablecoin to Compete with Crypto Industry

Key Takeaways: Powered by lumidawealth.com Major U.S. banks, including JPMorgan Chase, Bank of America, Citigroup, and Wells Fargo, are in early discussions to create a joint stablecoin to compete...

Read more

Bitcoin Hits $110K, But Traders Aggressively Short Amid Record Highs

by Team Lumida
1 week ago
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Key Takeaways: Powered by lumidawealth.com Bitcoin surged to a new record high above $110,000, liquidating $500 million in derivatives positions, but traders are aggressively shorting, with the long/short ratio...

Read more

Bitcoin Hits Record Close at $106,830, Eyes $110K as Next Key Level

by Team Lumida
2 weeks ago
Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Key Takeaways: Powered by lumidawealth.com Bitcoin (BTC) closed at a record daily high of $106,830 (UTC), driven by increased investment in spot ETFs and concerns over fiscal health in...

Read more

Stablecoin Bill Advances in U.S. Senate, Marking a Major Win for the Crypto Industry

by Team Lumida
2 weeks ago
Bitcoin Mining Stocks Outperform BTC in Early 2025, Network Strength Grows

Key Takeaways: Powered by lumidawealth.com The U.S. Senate voted 66-32 to end a filibuster on stablecoin legislation, paving the way for debate and a potential vote as early as...

Read more

Coinbase Faces $400 Million Cyberattack Hit Amid SEC Scrutiny and S&P 500 Inclusion

by Team Lumida
2 weeks ago
Coinbase’s $25M Boost to Crypto’s Biggest Political War Chest Yet

Key Takeaways: Powered by lumidawealth.com Coinbase disclosed a potential $180 million to $400 million financial impact from a cyberattack that compromised customer data, including names, addresses, and emails, but...

Read more
Next Post
Nvidia CEO Reveals Secrets Behind AI Domination Amidst Fierce Competition

Nvidia Shares Tumble Amid Double Threat of Trump Tariffs and AI Competition

black and gray metal pipe

Trump's Steel Tariffs 2.0: North American Trade Tensions Rise as Steel Prices Surge

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Japan’s GPIF Falls Behind Norway Amid Currency Woes

Japan’s Inflation Hits New Highs: Is a Rate Hike Imminent?

July 19, 2024
Chinese Stock Surge: A Hedge Fund Headache?

China’s Central Bank Halts Bond Purchases Amid Record-Low Yields and Yuan Pressure

January 10, 2025
orange and white medication pill

Drugmakers Navigate Trump Era with Modest 4% Price Hikes Despite High-Value Medications

January 28, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018